These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18802924)

  • 21. Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.
    Kambeitz J; Romanos M; Ettinger U
    Pharmacogenomics J; 2014 Feb; 14(1):77-84. PubMed ID: 23588108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of the dopamine transporter gene and ADHD symptoms in a Canadian population-based sample of same-age twins.
    Ouellet-Morin I; Wigg KG; Feng Y; Dionne G; Robaey P; Brendgen M; Vitaro F; Simard L; Schachar R; Tremblay RE; Pérusse D; Boivin M; Barr CL
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1442-9. PubMed ID: 18165969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of an association between 10/10 genotype of DAT1 and endophenotypes of attention deficit/hyperactivity disorder.
    Agudelo JA; Gálvez JM; Fonseca DJ; Mateus HE; Talero-Gutiérrez C; Velez-Van-Meerbeke A
    Neurologia; 2015 Apr; 30(3):137-43. PubMed ID: 24461309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD.
    Bellgrove MA; Barry E; Johnson KA; Cox M; Dáibhis A; Daly M; Hawi Z; Lambert D; Fitzgerald M; McNicholas F; Robertson IH; Gill M; Kirley A
    Neuropsychopharmacology; 2008 Sep; 33(10):2536-45. PubMed ID: 18046306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enlarged striatal volume in adults with ADHD carrying the 9-6 haplotype of the dopamine transporter gene DAT1.
    Onnink AM; Franke B; van Hulzen K; Zwiers MP; Mostert JC; Schene AH; Heslenfeld DJ; Oosterlaan J; Hoekstra PJ; Hartman CA; Vasquez AA; Kan CC; Buitelaar J; Hoogman M
    J Neural Transm (Vienna); 2016 Aug; 123(8):905-15. PubMed ID: 26935821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association study of promoter polymorphisms at the dopamine transporter gene in Attention Deficit Hyperactivity Disorder.
    Xu X; Mill J; Sun B; Chen CK; Huang YS; Wu YY; Asherson P
    BMC Psychiatry; 2009 Feb; 9():3. PubMed ID: 19196467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The VNTR polymorphism in the human dopamine transporter gene: improved detection and absence of association of VNTR alleles with attention-deficit hyperactivity disorder.
    Simsek M; Al-Sharbati M; Al-Adawi S; Lawatia K
    Genet Test; 2006; 10(1):31-4. PubMed ID: 16545000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The SLC6A3 gene polymorphism is related to the development of attentional functions but not to ADHD.
    Kuc K; Bielecki M; Racicka-Pawlukiewicz E; Czerwinski MB; Cybulska-Klosowicz A
    Sci Rep; 2020 Apr; 10(1):6176. PubMed ID: 32277231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).
    Kooij JS; Boonstra AM; Vermeulen SH; Heister AG; Burger H; Buitelaar JK; Franke B
    Am J Med Genet B Neuropsychiatr Genet; 2008 Mar; 147B(2):201-8. PubMed ID: 17955457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects.
    Spencer TJ; Biederman J; Faraone SV; Madras BK; Bonab AA; Dougherty DD; Batchelder H; Clarke A; Fischman AJ
    Biol Psychiatry; 2013 Jul; 74(2):84-9. PubMed ID: 23273726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional analysis of intron 8 and 3' UTR variable number of tandem repeats of SLC6A3: differential activity of intron 8 variants.
    Hill M; Anney RJ; Gill M; Hawi Z
    Pharmacogenomics J; 2010 Oct; 10(5):442-7. PubMed ID: 20029387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study.
    Smith KM; Daly M; Fischer M; Yiannoutsos CT; Bauer L; Barkley R; Navia BA
    Am J Med Genet B Neuropsychiatr Genet; 2003 May; 119B(1):77-85. PubMed ID: 12707943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of the DAT1 polymorphism with attention deficit hyperactivity disorder (ADHD): a family-based approach.
    Lim MH; Kim HW; Paik KC; Cho SC; Yoon DY; Lee HJ
    Am J Med Genet B Neuropsychiatr Genet; 2006 Apr; 141B(3):309-11. PubMed ID: 16526026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD.
    Contini V; Victor MM; Marques FZ; Bertuzzi GP; Salgado CA; Silva KL; Sousa NO; Grevet EH; Belmonte-de-Abreu P; Bau CH
    J Neural Transm (Vienna); 2010 Feb; 117(2):269-76. PubMed ID: 20049490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD.
    Dresler T; Ehlis AC; Heinzel S; Renner TJ; Reif A; Baehne CG; Heine M; Boreatti-Hümmer A; Jacob CP; Lesch KP; Fallgatter AJ
    Neuropsychopharmacology; 2010 Oct; 35(11):2193-202. PubMed ID: 20631685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of ADHD with genetic variants in the 5'-region of the dopamine transporter gene: evidence for allelic heterogeneity.
    Brookes KJ; Xu X; Anney R; Franke B; Zhou K; Chen W; Banaschewski T; Buitelaar J; Ebstein R; Eisenberg J; Gill M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Sonuga-Barke E; Steinhausen HC; Taylor E; Faraone SV; Asherson P
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1519-23. PubMed ID: 18668530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Family-based and case-control association studies of DRD4 and DAT1 polymorphisms in Chinese attention deficit hyperactivity disorder patients suggest long repeats contribute to genetic risk for the disorder.
    Qian Q; Wang Y; Zhou R; Yang L; Faraone SV
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jul; 128B(1):84-9. PubMed ID: 15211638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.
    Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD
    Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample.
    Kim JW; Kim BN; Cho SC
    J Psychiatr Res; 2006 Dec; 40(8):730-7. PubMed ID: 16368111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.